The problem of strict image-based inclusion criteria for mechanical thrombectomy - an analysis of stroke patients with an initial low CBV-ASPECTS score.
Aged
Aged, 80 and over
Cerebral Angiography
/ methods
Computed Tomography Angiography
/ methods
Endovascular Procedures
/ methods
Female
Humans
Male
Mechanical Thrombolysis
/ methods
Multidetector Computed Tomography
/ methods
Patient Selection
Retrospective Studies
Risk Factors
Stroke
/ diagnostic imaging
Alberta Stroke Program Early CT Score
Endovascular treatment
acute stroke
outcome
Journal
The neuroradiology journal
ISSN: 2385-1996
Titre abrégé: Neuroradiol J
Pays: United States
ID NLM: 101295103
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
pubmed:
18
5
2019
medline:
7
1
2020
entrez:
18
5
2019
Statut:
ppublish
Résumé
Endovascular treatment for acute ischaemic stroke with large artery occlusion has become the standard of care. However, the question if a subgroup of patients, with a low cerebral blood volume Alberta Stroke Program Early CT score (CBV-ASPECTS) ≤ 7 should be excluded from endovascular treatment remains open. Therefore; we investigated the difference of outcome between patients who were treated by endovascular treatment vs patients who did not receive endovascular treatment. We retrospectively analysed our stroke database for all patients who presented within six hours of onset with unfavourable imaging findings and who received endovascular treatment or best medical treatment alone. Unfavourable imaging was defined as a CBV-ASPECTS ≤ 7, which was an exclusion criterion for endovascular treatment at our institution before 2015. From 60 patients with an initial CBV-ASPECTS ≤ 7, 40 received best medical treatment and 20 were treated with endovascular treatment. Arterial hypertension and atrial fibrillation was more present in patients without endovascular treatment, the other baseline characteristics and percentage of patients treated with intravenous recombinant tissue plasminogen activator were not significantly different in both groups. At discharge, 40% of the interventional treated patients had a favourable outcome (eight of 20 (40%) vs six of 40 (15%; Patients with a CBV-ASPECTS ≤ 7 are likely to benefit from therapy and therefore may not be excluded from endovascular treatment. Further randomised trials are warranted to validate the data.
Identifiants
pubmed: 31099713
doi: 10.1177/1971400918791700
pmc: PMC6639637
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
287-293Références
Stroke. 2003 Aug;34(8):1925-31
pubmed: 12843342
N Engl J Med. 2013 Mar 7;368(10):904-13
pubmed: 23387822
N Engl J Med. 2013 Mar 7;368(10):893-903
pubmed: 23390923
N Engl J Med. 2013 Mar 7;368(10):914-23
pubmed: 23394476
Stroke. 2013 Aug;44(8):2188-93
pubmed: 23715960
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
Eur Radiol. 2016 Nov;26(11):4213-4219
pubmed: 26905866
Lancet Neurol. 2016 Jun;15(7):685-694
pubmed: 27302238
JAMA. 2016 Sep 27;316(12):1279-88
pubmed: 27673305
J Neurointerv Surg. 2017 Dec;9(12):1223-1227
pubmed: 27998957
Clin Neuroradiol. 2018 Sep;28(3):327-338
pubmed: 28194477
PLoS One. 2017 Mar 10;12(3):e0173737
pubmed: 28282456
Neuroradiol J. 2017 Apr;30(2):138-143
pubmed: 28424017
Stroke. 2017 Nov;48(11):3152-3155
pubmed: 29018132
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
Stroke. 1998 Jan;29(1):4-11
pubmed: 9445320